BUL02, Placebo orodispersible tablets, BUL03
BUL-5/ESD
Phase 2 small_molecule active
Quick answer
BUL02, Placebo orodispersible tablets, BUL03 for Prevention of oesophageal strictures in adult patients after endoscopic submucosal dissection is a Phase 2 program (small_molecule) at Dr. Falk Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dr. Falk Pharma GmbH
- Indication
- Prevention of oesophageal strictures in adult patients after endoscopic submucosal dissection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active